Diabetes, Obesity and Metabolism Diabetes, Obesity and Metabolism RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Comparative effectiveness of canagliflozin, SGLT2 inhibitors and non ‐SGLT2 inhibitors on the risk of hospitalization for heart failure and amputation in patients with type 2 diabetes mellitus: A real‐world meta‐analysis of 4 observational databases (OBSERVE‐4D)
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - June 25, 2018 Category: Endocrinology Authors: Patrick B. Ryan PhD , John B. Buse MD , Martijn J. Schuemie PhD , Frank DeFalco BA , Zhong Yuan MD, PhD , Paul E. Stang PhD , Jesse A. Berlin ScD , Norman Rosenthal MD Source Type: research

Clinical outcomes in real ‐world patients with type 2 diabetes switching from first‐ to second‐generation basal insulin analogues: Comparative effectiveness of insulin glargine 300 units/mL and insulin degludec in the DELIVER D+ cohort study
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - June 25, 2018 Category: Endocrinology Authors: Sean D. Sullivan PhD , Timothy S. Bailey MD , Ronan Roussel MD , Fang Liz Zhou MD , Zsolt Bosnyak MD , Ronald Preblick PharmD , Jukka Westerbacka MD , Rishab A. Gupta MTech , Lawrence Blonde MD Source Type: research

The management of type 2 diabetes with fixed ‐ratio combination insulin degludec/liraglutide (IDegLira) versus basal‐bolus therapy (insulin glargine U100 plus insulin aspart): A short‐term cost‐effectiveness analysis in the UK setting
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - June 25, 2018 Category: Endocrinology Authors: Russell Drummond MD , Samuel Malkin BSc , Michelle Du Preez BSc , Xin Ying Lee MSc , Barnaby Hunt MSc Source Type: research

Comparison of pancreatic volume and fat amount linked with glucose homeostasis between healthy Caucasians and Koreans
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - June 23, 2018 Category: Endocrinology Authors: Eun Roh MD , Kyoung Min Kim MD, PhD , Kyeong Seon Park MD , Yoon Ji Kim MD , Eun Ju Chun MD, PhD , Sung Hee Choi MD, PhD , Kyong Soo Park MD, PhD , Hak Chul Jang MD, PhD , Soo Lim MD, PhD Source Type: research

Acute vs Cumulative Benefits of Metformin use in Patients with Type 2 Diabetes and Heart Failure
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - June 23, 2018 Category: Endocrinology Authors: Daniala L. Weir MSc , Michal Abrahamowicz PhD , Marie ‐Eve Beauchamp PhD , Dean T. Eurich PhD Source Type: research

Nonadherence to Basal Insulin Among Patients With Type 2 Diabetes in a US Managed Care Population: Results from a Patient Survey
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - June 22, 2018 Category: Endocrinology Authors: Judith J. Stephenson SM , Amit D. Raval PhD , David M. Kern PhD , Jay P. Bae PhD Source Type: research

Impact of macronutrient content of meals on postprandial glucose control in the context of closed ‐loop insulin delivery – a randomized cross‐over study
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - June 22, 2018 Category: Endocrinology Authors: V éronique Gingras RD, PhD , Lisa Bonato MD , Virginie Messier MSc , Amélie Roy‐Fleming RD , Mohamed Raef Smaoui PhD , Martin Ladouceur PhD , Rémi Rabasa‐Lhoret MD, PhD Source Type: research

Insulin therapy, weight gain and prognosis
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - June 22, 2018 Category: Endocrinology Authors: Israel Hodish MD Source Type: research

Lipid ‐lowering medication is associated with decreased risk of diabetic retinopathy and the need for treatment in patients with type 2 diabetes: A real‐world observational analysis of a health claims database
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - June 21, 2018 Category: Endocrinology Authors: Ryo Kawasaki PhD , Tsuneo Konta PhD , Kohji Nishida PhD Source Type: research

Short ‐term effects of dapagliflozin on insulin sensitivity, postprandial glucose excursion, and ketogenesis in type 1 diabetes – a randomized, placebo‐controlled, double blind, cross‐over pilot study
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - June 20, 2018 Category: Endocrinology Authors: A. Melmer , P. Kempf , L. Lunger , T.R. Pieber , J.K. Mader , C. Stettler , H. Tilg , C.F. Ebenbichler , M. Laimer Source Type: research

Low Incidence of Gastrointestinal Adverse Events Over Time with a Fixed ‐Ratio Combination of Insulin Glargine and Lixisenatide vs Lixisenatide Alone
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - June 20, 2018 Category: Endocrinology Authors: Jennifer M. Trujillo PharmD, FCCP, BCPS, CDE, BC ‐ADM , Michelle Roberts MD , Terry Dex PharmD , Jason Chao MS , PA‐C John White PharmD , James LaSalle DO Source Type: research

Efficacy of iGlarLixi, a fixed ‐ratio combination of insulin glargine and lixisenatide, in patients with type 2 diabetes stratified as high and low risk according to HEDIS measures
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - June 20, 2018 Category: Endocrinology Authors: Danny H. Sugimoto , Terry Dex , William Stager , Vanita R. Aroda Source Type: research

Dapagliflozin, a SGLT2 inhibitor, slows the progression of renal complications through the suppression of renal inflammation, ER stress, and apoptosis in pre ‐diabetic rats
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - June 20, 2018 Category: Endocrinology Authors: Krit Jaikumkao , Anchalee Pongchaidecha , Nuttawud Chueakula , La ‐ongdao Thongnak , Keerati Wanchai , Varanuj Chatsudthipong , Nipon Chattipakorn , Anusorn Lungkaphin Source Type: research

Efficacy and Safety of the Glucagon Receptor Antagonist PF ‐06291874: A 12‐Week, Randomized, Dose‐Response Study in Patients With Type 2 Diabetes Mellitus on Background Metformin Therapy
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - June 20, 2018 Category: Endocrinology Authors: David J. Kazierad PharmD , Kristin Chidsey MA, MBA , Veena R. Somayaji PhD , Arthur J. Bergman PhD , Roberto A. Calle MD Source Type: research

Ultra ‐rapid BioChaperone Lispro Improves post‐prandial Blood Glucose Excursions versus Insulin Lispro in a 14‐day crossover Treatment Study in Patients with Type 1 Diabetes
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - June 20, 2018 Category: Endocrinology Authors: Grit Andersen , Gr égory Meiffren , Daniela Lamers , J. Hans DeVries , Aymeric Ranson , Cyril Seroussi , Bertrand Alluis , Martin Gaudier , Olivier Soula , Tim Heise Source Type: research